How Much Did BioThrive Sciences Raise?
Funding & Key Investors

BioThrive Sciences has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total funding accumulation of $250K, the firm is well-positioned to scale its operations within the competitive nutraceutical landscape. This recent funding amount of $250K serves as a major strategic investment, providing the necessary liquidity to bolster its manufacturing infrastructure and expand its private label service offerings for a global client base.

What is BioThrive Sciences?

BioThrive Sciences
ManufacturingHealth & Nutrition ProductsPharmaceuticals

BioThrive Sciences operates as a premier GMP-certified manufacturer, maintaining rigorous FDA registration to ensure the highest standards of quality and compliance in the dietary supplement sector. The company distinguishes itself through a comprehensive service model that encompasses the entire product lifecycle, from the development of customized formulas to large-scale manufacturing and end-to-end fulfillment. By specializing in vitamins, sports nutrition, and advanced skin care solutions, BioThrive Sciences effectively bridges the gap between complex formulation requirements and the growing demand for high-quality, USA-made health products. Their market position is reinforced by a commitment to transparency and regulatory excellence, making them a preferred partner for businesses seeking reliable private label manufacturing solutions.

How much funding has BioThrive Sciences raised?

BioThrive Sciences has raised a total of $250K across 1 funding round:

2024

Debt

$250K

Debt (2024): $250K, investors not publicly disclosed

Key Investors in BioThrive Sciences

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for BioThrive Sciences?

With this latest infusion of capital, BioThrive Sciences is poised to accelerate its growth strategy by optimizing its production facilities and enhancing its supply chain resilience. The company is expected to leverage these resources to deepen its penetration into the health-conscious consumer market, potentially diversifying its product portfolio to include emerging wellness categories. As the firm transitions into this next phase of development, the focus will likely shift toward operational efficiency and the scaling of its private label division to meet the increasing demand for bespoke, compliant health solutions. This strategic move underscores the company's intent to solidify its leadership in the contract manufacturing space while maintaining the stringent quality controls that define its brand identity.

See full BioThrive Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingTextiles & ApparelApparel & Accessories RetailRetail
ManufacturingPlastic, Packaging & Containers
Industrial Machinery & EquipmentManufacturing
ManufacturingPulp & Paper

Frequently Asked Questions Regarding BioThrive Sciences Financial Insights

What are the most recent funding rounds that BioThrive Sciences has completed, and what were the funding rounds?
BioThrive Sciences has recently completed 1 funding rounds: Debt on Dec 31, 2024.
What is the total amount of funding BioThrive Sciences has raised to date?
BioThrive Sciences has raised a total of $250K in funding to date.
How many funding rounds has BioThrive Sciences completed?
BioThrive Sciences has completed 1 funding rounds.
How much funding did BioThrive Sciences raise in its most recent funding round?
BioThrive Sciences raised $250K in its most recent funding round.
Which was the largest funding round in BioThrive Sciences's history?
The largest funding round in BioThrive Sciences's history was $250K.
See more information about BioThrive Sciences